This article conducts a comprehensive review of both traditional therapeutic application knowledge and contemporary literature pertaining to Choerospondias axillaris (Roxb.) Burtt et Hill. Traditional application information was gathered from relevant reports, books, and classic material medica. Research literature and dissertations on C. axillaris chemical constituents and pharmacological activities, available up to 2023, were sourced from electronic databases. Pharmaceutical components such as flavonoids, phenolic acids, triterpenes, lignans, and organic acids were identified in C. axillaris and categorized based on their relevance to cardiovascular roles. Examining the material basis for C. axillaris efficacy in addressing cardiovascular diseases, an analysis of 27 Chinese patent medicines containing Choerospondiatis Fructus (CF) highlighted Myristicae Semen as the most frequently utilized and strongly associated with CF in prescriptions. C. axillaris exhibited notable pharmacological effects, encompassing anti-myocardial ischemia-reperfusion injury, anti-arrhythmic properties, anti-myocardial fibrosis, and hemorheological effects linked to cardiovascular diseases. This review aspires to provide valuable insights for translating traditional applications into modern pharmaceuticals and offers guidance for clinical applications in cardiovascular interventions.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |